• Jobs
  • Startups
  • Hire
LoginSign up

Satellite Bio

Organization banner, image 1 of 3
Organization banner, image 2 of 3
Organization banner, image 3 of 3

Satellite Bio has 3 open roles, all posted in the last 30 days. Funding stage: Series A. Last round: $82.5M, Mar 7, 2022.

Open roles

  • Satellite Bio logo
    Biostatistics Consultant, Part-Time Contractor

    Satellite Bio

    • Watertown, MA
    • On-site
    satellite.bio
  • Satellite Bio logo
    Vice President, Clinical Development

    Satellite Bio

    • Watertown, MA
    • On-site · Director / Executive
    satellite.bio
  • Satellite Bio logo
    Vice President, Clinical Development

    Satellite Bio

    • Newton, MA
    • On-site · Director / Executive
    satellite.bio

About

Satellite Bio logo

Satellite Bio

Tackling some of humankind’s most elusive diseases with Tissue Therapeutics, a new category of regenerative medicine

At Satellite Bio, we’re on a journey – a quest to treat some of the most elusive diseases known to humankind by pioneering Tissue Therapeutics, an entirely new category of regenerative medicine. With the first-of-its-kind SAT (Satellite Adaptive Tissues) platform, Satellite Bio can turn virtually any cell type into bioengineered tissues that are integrated into the body to restore natural function. These tissues, called Satellites, can deliver the comprehensive cellular response needed to repair or even replace critical organ functions in patients with diseases caused by the interaction of genetic and environmental factors. The SAT platform is an unprecedented technology with the potential to drive a pipeline of sophisticated cell-based therapeutic solutions that tackle a broad range of elusive diseases. Satellite Bio’s quest is as audacious as it is clear: bring new hope to patients and families suffering from elusive diseases. Tissue Therapeutics is how it will deliver on that prom

Private companySeries A
Founded2019
HQCambridge, United States
Unlock human wisdom
ThesisTermsPrivacy
Size
24 employees
IndustryBiotechnology Research
Funding
  • Series A · $82.5M · Mar 7, 2022
Investors
Lightspeed Venture PartnersPolaris PartnersaMoon Fund

Claim satellite.bio

Work at satellite.bio? Sign in to claim this org and manage its profile.

© 2026 Saywise Inc.